Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Seronegativity”

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT00068991
What this trial is testing

HIV Educational Programs for Villagers of Funan County or Yingzhou District, Anhui Province, China

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT01040091
What this trial is testing

Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 34
Early research (Phase 1)Study completedNCT00000868
What this trial is testing

Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative Volunteers

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 27
Early research (Phase 1)Study completedNCT00002232
What this trial is testing

GENEVAX-HIV, a Possible Vaccine

Who this might be right for
HIV InfectionsHIV Seronegativity
Wyeth-Lederle Vaccines
Early research (Phase 1)Study completedNCT00001026
What this trial is testing

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 56
Large-scale testing (Phase 3)Study completedNCT00619320
What this trial is testing

Reducing HIV: Safer Sex Skill Building in Pregnant Drug Abusing Women

Who this might be right for
HIV InfectionsSubstance Use
Virginia Commonwealth University 380
Not applicableStudy completedNCT00729573
What this trial is testing

Bone Mineral Density Substudy - An Ancillary Study to MTN-003

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 518
Testing effectiveness (Phase 2)Study completedNCT00161343
What this trial is testing

Maintaining HIV Prevention Gains in Female Adolescents

Who this might be right for
HIV InfectionSexually Transmitted Diseases
University of Rochester 640
Early research (Phase 1)Ended earlyNCT00637962
What this trial is testing

Reactogenicity and Immunogenicity of Vaginal CNgp140

Who this might be right for
HIV InfectionsAcquired Immune Deficiency Syndrome
St George's, University of London 23
Early research (Phase 1)Study completedNCT00000832
What this trial is testing

A Randomized, Placebo-Controlled, Double-Blinded Phase I Safety and Immunogenicity Trial of Recombinant Envelope Protein, HIV-1 SF-2 rgp120 (BIOCINE), Combined With MF59 in HIV-1 Uninfected Adult Volunteers

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Not applicableStudy completedNCT00891358
What this trial is testing

Empowerment Intervention for Young Women - Phase I

Who this might be right for
HIVEmpowermentHIV Infections
University of North Carolina, Chapel Hill 17
Early research (Phase 1)Study completedNCT00121121
What this trial is testing

Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult Volunteers

Who this might be right for
HIV InfectionsHIV Seronegativity
French National Agency for Research on AIDS and Viral Hepatitis 70
Testing effectiveness (Phase 2)Study completedNCT00548275
What this trial is testing

Reducing Sex-Related HIV Risk Behaviors in Patients Receiving Treatment for Opioid Dependence

Who this might be right for
Opiate DependenceHIV Infections
Yale University 22
Large-scale testing (Phase 3)Study completedNCT00223080
What this trial is testing

HIV Vaccine Trial in Thai Adults

Who this might be right for
HIV Infection
U.S. Army Medical Research and Development Command 16,402
Early research (Phase 1)Study completedNCT00000775
What this trial is testing

A Phase I Safety and Immunogenicity Trial of UBI SynVac (HIV-1 MN Octameric V3 Peptide Vaccine)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Early research (Phase 1)Study completedNCT00332995
What this trial is testing

Safety and Feasibility Study of Dapivirine (TMC120) Vaginal Ring in Belgium

Who this might be right for
HIV Infections
International Partnership for Microbicides, Inc. 13
Early research (Phase 1)Study completedNCT00680719
What this trial is testing

Preventing HIV/Aids in Drug Abusing Youth

Who this might be right for
HIV Infections
Oregon Research Institute 111
Post-approval studies (Phase 4)Study completedNCT00385645
What this trial is testing

Atazanavir or Lopinavir in HIV Post-exposure Prophylaxis

Who this might be right for
HIV Infections
Hospital Clinic of Barcelona 255
Early research (Phase 1)UnknownNCT00214812
What this trial is testing

An Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Assessment of Bare Spots

Who this might be right for
HIV Infections
Biosyn 6
Early research (Phase 1)Study completedNCT00001019
What this trial is testing

Safety of and Immune Response to an HIV Vaccine (SF-2 gp120) With or Without MTP-PE/MF59 Adjuvant

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation